Platelets in defense against bacterial pathogens

Cellular and Molecular Life Sciences

Volumn 67, Issue 4, 2010, Pages 525-544

  Yeaman, Michael R ^a  

^a St John's Cardiovascular Research Center   (United States)

Author keywords

Bacteria; Host defenses; Interactions; Pathogen; Platelets

Indexed keywords

BACTERIAL PROTEIN; CELL PROTEIN; KINOCIDIN; MICROBICIDE; PLATELET MICROBICIDAL PROTEIN; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANTIMICROBIAL ACTIVITY; BACTERIAL IMMUNITY; BACTERIAL INFECTION; BACTERIAL VIRULENCE; EFFECTOR CELL; ENDOTHELIUM CELL; GRANULOCYTE; HOST RESISTANCE; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNITY; IMMUNOBIOLOGY; INNATE IMMUNITY; MOLECULAR INTERACTION; NONHUMAN; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOCYTE STRUCTURE; ANIMAL; BACTERIUM; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGY; LEUKOCYTE; MICROBIOLOGY; PATHOGENICITY;

BACTERIA (MICROORGANISMS);

ANIMALS; BACTERIA; BACTERIAL INFECTIONS; BLOOD PLATELETS; HOST-PATHOGEN INTERACTIONS; HUMANS; LEUKOCYTES;

EID: 75649135573     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-009-0210-4     Document Type: Review

References (194)

1. Yeaman MR, Bayer AS (2006) Platelets in antimicrobial host defense. In: Michelson A (ed) Platelets, 2nd edn. Academic, New York, pp 727-755
2. Nachum R, Watson SW, Sullivan JD Jr, Siegel SE (1980) Antimicrobial defense mechanisms in the horseshoe crab, Limulus polyphemus: preliminary observations with heat-derived extracts of Limulus amoebocyte lysate. J Invertebr Pathol 32:51-58
3. Maluf NSR (1939) The blood of arthropods. Q Rev Biol 14:149-191
4. Weksler BB (1992) Platelets. In: Gallin JI, Goldstein IM, Sny-derman R (eds) Inflammation: basic principles and clinical correlates, 2nd edn. Raven, New York, pp 543-557
5. Tocantins LM (1938) The mammalian blood platelet in health and disease. Medicine 17:155-257
6. Klinger MH, Jelkmann W (2002) Role of blood platelets in infection and inflammation. J Interferon Cytokine Res 22:913-922
7. Yeaman MR (1997) The role of platelets in antimicrobial host defense. Clin Infect Dis 25:951-968
8. Yeaman MR, Bayer AS (1999) Antimicrobial peptides from platelets. Drug Resist Updat 2:116-126
9. Elzey BD, Sprague DL, Ratliff TL (2005) The emerging role of platelets in adaptive immunity. Cell Immunol 238:1-9
10. Fitzgerald JR, Foster TJ, Cox D (2006) The interaction of bacterial pathogens with platelets. Nat Rev Microbiol 4:445-457
11. Ford I, Douglas CW (1997) The role of platelets in infective endocarditis. Platelets 8:285-294
12. White JG (1972) Platelet morphology and function. In: Williams WJ, Beutler E, Erslev AJ, Rundles RW (eds) Hematology. McGraw-Hill, New York, pp 1023-1039
13. Marcus AJ (1969) Platelet function. N Eng J Med 280: 1213, 1278, 1330
14. 14C-labelled serotonin. J Clin Invest 40:2134-2138
15. Murphy EA, Robinson GA, Rowsell A (1967) The pattern of platelet disappearance. Blood 30:26-31
16. Harker LA, Finch CA (1969) Thrombokinetics in man. J Clin Invest 48:963-1969
17. Colman RW (1991) Receptors that activate platelets. Proc Soc Exp Biol Med 197:242-248
18. MacFarlane DE, Mills DCB (1975) The effects of ATP on platelets: evidence against the central role of released ADP in primary aggregation. Blood 46:309-314
19. MacFarlane DE, Walsh PN, Mills DCB, Holmsen H, Day HJ (1975) The role of thrombin in ADP-induced platelet aggregation and release: a critical evaluation. Br J Haematol 30:457-464
20. Davies TA, Fine RE, Johnson RJ, Levesque CA, Rathbun WH, Seetoo KF, Smith SJ, Strohmeier G, Volicer L, Delva L, Simons ER (1993) Non-age related differences in thrombin responses by platelets from male patients with advanced Alzheimer's disease. Biochem Biophys Res Commun 194:537-543
21. Rosenfeld SI, Looney RJ, Leddy JP (1985) Human platelet Fc receptor of immunoglobulin G. J Clin Invest 76:2317-2322
22. Joseph M, Auriault C (1983) A new function for platelets: IgE-dependent killing of schistosomes. Nature 303:810-812
23. Bout D, Joseph M, Ponet M (1986) Rat resistance to schisto-somiasis: platelet-mediated cytotoxicity induced by C-reactive protein. Science 231:153-156
24. Ochenhouse CF, Magowan C, Chulay JD (1989) Activation of monocytes and platelets by monoclonal antibodies or malaria-infected erythrocytes binding to CD36 surface receptor in vitro. J Clin Invest 84:468-475
25. Cosgrove LJ, de Apice AJ, Haddad A, Pedersen J, McKenzie IF (1987) CR3 receptors on platelets and it role in the prostaglandin metabolic pathway. Immunol Cell Biol 65:453-460
26. Pancré V, Monte D, Delanoye A, Capron A, Auriault C (1990) Interleukin-6, the main mediator of interaction between mono-cytes and platelets in killing of Schistosoma mansoni. Eur Cytokine Netw 1:15-19
27. Peng J, Friese P, George JN, Dale GL, Burstein SA (1994) Alteration of platelet function in dogs mediated by interleukin-6. Blood 83:398-403
28. Clemetson KJ, Clemetson JM, Proudfoot AE, Power CA, Bag-giolini M, Wells TN (2000) Functional expression of CCR1, CCR3, CCR4, and CXCR4 chemokine receptors on human platelets. Blood 96:4046-4054
29. 2 accounts for bronchoconstriction, but not for platelet sequestration and microvascular albumin exchanges induced by f-met-leu-phe in the guinea pig lung. J Pharmacol Exp Ther 260:8832-8840
30. Coyle AJ, Vargaftig BB (1995) Animal models for investigating the allergic and inflammatory properties of platelets. In: Joseph M (ed) Immunopharmacology of platelets. Academic, London, pp 21-30
31. Czapiga M, Gao JL, Kirk A, Lekstrom-Himes J (2005) Human platelets exhibit chemotaxis using functional N-formyl peptide receptors. Exp Hematol 33:73-84
32. Jaff MS, McKenna D, McCann SR (1985) Platelet phagocytosis: a probable mechanism of thrombocytopenia in Plasmodium falciparum infection. J Clin Pathol 38:1318-1319
33. Movat HZ, Weiser WJ, Glynn MF, Mustard JF (1965) Platelet phagocytosis and aggregation. J Cell Biol 27:531-543
34. Cognasse F, Hamzeh H, Chavarin P, Acquart S, Genin C, Garraud O (2005) Evidence of Toll-like receptor molecules on human platelets. Immunol Cell Biol 83:196-198
35. Shiraki R, Inoue N, Kawasaki S, Takei A, Kadotani M, Ohnishi Y, Ejiri J, Kobayashi S, Hirata K, Kawashima S, Yokoyama M (2004) Expression of Toll-like receptors on human platelets. Thromb Res 113:379-385
36. Aslam R, Speck ER, Kim M, Crow AR, Bang KW, Nestel FP, Ni H, Lazarus AH, Freedman J, Semple JW (2006) Platelet Tolllike receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-alpha production in vivo. Blood 107:637-641
37. Cognasse F, Hamzeh-Cognasse H, Lafarge S, Delezay O, Poz-zetto B, McNicol A, Garraud O (2008) Toll-like receptor 4 ligand can differentially modulate the release of cytokines by human platelets. Br J Haematol 141:84-91
38. Blair P, Rex S, Vitseva O, Beaulieu L, Tanriverdi K, Chak-rabarti S, Hayashi C, Genco CA, Iafrati M, Freedman JE (2009) Stimulation of Toll-like receptor 2 in human platelets induces a thromboinflammatory response through activation of phospho-inositide 3-kinase. Circ Res 104:346-354
39. Zhang G, Han J, Welch EJ, Ye RD, Voyno-Yasenetskaya TA, Malik AB, Du X, Li Z (2009) Lipopolysaccharide stimulates platelet secretion and potentiates platelet aggregation via TLR4/ MyD88 and the cGMP-dependent protein kinase pathway. J Immunol 182:7997-8004
40. Clark SR, Ma AC, Tavener SA, McDonald B, Goodarzi Z, Kelly MM, Patel KD, Chakrabarti S, McAvoy E, Sinclair GD, Keys EM, Allen-Vercoe E, Devinney R, Doig CJ, Green FH, Kubes P (2007) Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat Med 13:463-469
41. Scott T, Owens MD (2008) Thrombocytes respond to lipo-polysaccharide through Toll-like receptor-4, and MAP kinase and NF-kappaB pathways leading to expression of interleukin-6 and cyclooxygenase-2 with production of prostaglandin E2. Mol Immunol 45:1001-1008
42. Miedzobrodzki J, Panz T, Płonka PM, Zajac K, Dracz J, Pytel K, Mateuszuk Ł, Chłopicki S (2008) Platelets augment respiratory burst in neutrophils activated by selected species of gram-positive or gram-negative bacteria. Folia Histochem Cytobiol 46:383-388
43. Blumberg N, Spinelli SL, Francis CW, Taubman MB, Phipps RP (2009) The platelet as an immune cell-CD40 ligand and transfusion immunomodulation. Immunol Res. 2009 [Epub ahead of print]
44. Bancsi MJLF, Thompson J, Bertina RM (1994) Stimulation of monocyte tissue factor expression in an in vitro model of bacterial endocarditis. Infect Immun 62:5669-5672
45. Drake TA, Pang M (1988) Staphylococcus aureus induces tissue factor expression in cultured human cardiac valve endothelium. J Infect Dis 157:749-756
46. Drake TA, Rodgers GM, Sande MA (1984) Tissue factor is a major stimulus for vegetation formation in enterococcal endocarditis in rabbits. J Clin Invest 73:1750-1753
47. White JG (1987) Views of the platelet at rest and at work. Ann NY Acad Sci 509:156-176
48. White JG, Sauk JJ (1984) Microtubule coils in spread blood platelets. Blood 64:470-478
49. Price B, Flaumenhaft R (2009) Platelet a-granules: basic biology and clinical correlates. Blood Rev 23:177-189
50. Scheld WM, Valone JA, Sande MA (1978) Bacterial adherence in the pathogenesis of infective endocarditis: interaction of dextran, platelets, & fibrin. J Clin Invest 61:1394-1404
51. Durack DT (1975) Experimental bacterial endocarditis. IV. Structure and evolution of very early lesions. J Clin Pathol 45:81-89
52. Calderone RA, Rotondo MF, Sande MA (1978) Candida albi-cans endocarditis: ultrastructural studies of vegetation formation. Infect Immun 20:279-289
53. Durack DT, Beeson PB, Petersdorf RG (1973) Experimental bacterial endocarditis. III. Production of progress of the disease in rabbits. Br J Exp Pathol 54:142-151
54. Sullam PM, Drake TA, Sande MA (1985) Pathogenesis of endocarditis. Am J Med 78(Suppl 6B):110-115
55. Ferguson DJP, McColm AA, Savage TJ, Ryan DM, Acred P (1986) A morphological study of experimental rabbit staphylo-coccal endocarditis and aortitis. I. Formation and effect of infected and uninfected vegetations on the aorta. Br J Exp Pathol 67:667-678
56. Scheld WM, Sande MA (1995) Endocarditis and intravascular infections. In: Mandell GL, Bennet JE, Dolin R (eds) Principles and practice of infectious diseases, 5th edn. Churchill Livingstone, New York, pp 740-782
57. Clawson CC (1977) Role of platelets in the pathogenesis of endocarditis. In: Infectious endocarditis. Am Heart Assoc Monogr 52:24-27
58. Roberts WC, Buchbinder NA (1972) Right-sided valvular infective endocarditis: a clinicopathologic study of 12 necropsy patients. Am J Med 53:7-19
59. Buchbinder NA, Roberts WC (1972) Left-sided valvular infective endocarditis: a study of 45 necropsy patients. Am J Med 53:20-35
60. Vinter DW, Burkel WE, Wakefield TW, Graham LM, Whitehouse WM Jr, Stanley JC, Ford JW (1984) Radioisotope-labeled platelet studies and infection of vascular grafts. J Vasc Surg 6:921-923
61. Osler W (1886) On certain problems in the physiology of the blood corpuscles. Med News 48:365-370, 393-399, 421-425
62. Cheung AL, Fischetti VA (1990) The role of fibrinogen in staphylococcal adherence to catheters in vitro. J Infect Dis 161:1177-1186
63. Piguet PF, Vesin C, Ryser JE, Senaldi G, Grau GF, Tachini-Cottier F (1993) An effector role for platelets in systemic and local lipopolysaccharide- induced toxicity in mice, mediated by a CD11a-and CD54a-dependent interaction with endothelium. Infect Immun 61:82-87
64. Smith CW (1993) Leukocyte-endothelial cell interaction. Semin Hematol 30:45-55
65. Maisch PA, Calderone RA (1980) Adherence of Candida albi-cans to a fibrin-platelet matrix formed in vitro. Infect Immun 27:650-656
66. Klotz SA, Harrison JL, Misra RP (1989) Aggregated platelets enhance adherence of Candida yeasts to endothelium. J Infect Dis 160:669-677
67. Yeaman MR, Norman DC, Bayer AS (1992) Staphylococcus aureus susceptibility to thrombin-induced platelet microbicidal protein is independent of platelet adherence or aggregation in vitro. Infect Immun 60:2368-2374
68. Sullam PM, Valone FH, Mills J (1987) Mechanisms of platelet aggregation by viridans group streptococci. Infect Immun 55:1743-1750
69. Robert R, Senet JM, Mahaza C, Annaix V, Miegeville M, Bouchara JP, Tronchin G, Marot-Leblond A (1992) Molecular basis of the interaction between Candida albicans, fibrinogen, and platelets. J Mycol Med 2:19-25
70. Herzberg MC, Brintzenhofe KL, Clawson CC (1983) Aggregation of human platelets and adhesion of Streptococcus sanguis. Infect Immun 39:1457-1469
71. Herzberg MC, Gong K, MacFarlane GD, Erickson PR, Soberay AH, Krebsbach PH, Gopalraj M, Schilling K, Bowen WH (1990) Phe-notypic characterization of Streptococcus sanguis virulence factors associated with bacterial endocarditis. Infect Immun 58:515-522
72. Nicolau DP, Freeman CD, Nightingale CH, Quintiliani R, Coe CJ, Maderazo EG, Cooper BW (1993) Reduction of bacterial titers by low-dose aspirin in experimental aortic valve endocarditis. Infect Immun 61:1593-1595
73. Clawson CC, White JG (1971) Platelet interaction with bacteria. II. Fate of bacteria. Am J Pathol 65:381-398
74. Clawson CC, White JG (1971) Platelet interaction with bacteria. I. Reaction phases and effects of inhibitors. Am J Pathol 65:367-380
75. Clawson CC (1973) Platelet interaction with bacteria. III. Ultrastructure. Am J Pathol 70:449-472
76. Clawson CC, Rao GHR, White JG (1975) Platelet interaction with bacteria. IV. Stimulation of the release reaction. Am J Pathol 81:411-420
77. Forrester LJ, Campbell BJ, Berg JN, Barrett JT (1985) Aggregation of platelets by Fusobacterium necrophorum. J Clin Microbiol 22:245-249
78. Czuprynski CJ, Balish E (1981) Interaction of rat platelets with Listeria monocytogenes. Infect Immun 33:103-108
79. Copley AL, Maupin B, Balea T (1959) The agglutinant and adhesive behaviour of isolated human and rabbit platelets in contact with various strains of mycobacteria. Acta Tuberc Scand 37:151-161
80. Kessler CM, Nussbaum E, Tuazon CU (1987) In vitro correlation of platelet aggregation with occurrence of disseminated intravascular coagulation and subacute bacterial endocarditis. J Lab Clin Med 109:647-652
81. Timmons S, Huzoor-Akbar A, Grabarek J, Kloczewiak M, Hawiger J (1986) Mechanism of human platelet activation by endotoxic glycolipid-bearing mutant Re595 of Salmonella minnesota. Blood 68:1015-1023
82. Mandell GL, Hook EW (1969) The interaction of platelets, Salmonella, and mouse peritoneal macrophages. Proc Soc Exp Biol Med 132:757-759
83. Simmonet M, Triadou P, Frehel C, Morel-Kopp M-C, Kaplan C, Berche P (1992) Human platelet aggregation by Yersinia pseudotuberculosis is mediated by invasin. Infect Immun 60:366-373
84. Sigurdsson AF, Gudmundsson S (1989) The etiology of bacterial cellulitis as determined by fine-needle aspiration. Scand J Infect Dis 21:537-542
85. Diekema DJ, Pfaller MA, Schmitz FJ, Smayevsky J, Bell J, Jones RN, Beach M (2001) Survey of infections due to Staph-ylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis 32:S114-S132
86. Carratala J, Roson B, Fernandez-Sabe N, Shaw E, del Rio O, Rivera A, Gudiol F (2003) Factors associated with complications and mortality in adult patients hospitalized for infectious cellulitis. Eur J Clin Microbiol Infect Dis 22:151-157
87. Brook I, Frazier EH (1995) Clinical features and aerobic and anaerobic microbiological characteristics of cellulitis. Arch Surg 130:786-792
88. Hoen B, Alla F, Selton-Suty C, Beguinot I, Bouvet A, Briancon S, Casalta JP, Danchin N, Delahaye F, Etienne J, Le Moing V, Leport C, Mainardi JL, Ruimy R, Vandenesch F (2002) Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA 288:75-81
89. Fowler VG Jr, Miro JM, Hoen B, Cabell CH, Abrutyn E, Rubinstein E, Corey GR, Spelman D, Bradley SF, Barsic B, Pappas PA, Anstrom KJ, Wray D, Fortes CQ, Anguera I, Athan E, Jones P, van der Meer JT, Elliott TS, Levine DP, Bayer AS (2005) Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA 293:3012-3021
90. Miro JM, Anguera I, Cabell CH, Chen AY, Stafford JA, Corey GR, Olaison L, Eykyn S, Hoen B, Abrutyn E, Raoult D, Bayer A, Fowler VG Jr (2005) Staphylococcus aureus native valve infective endocarditis: report of 566 episodes from the International Collaboration on Endocarditis Merged Database. Clin Infect Dis 41:507-514 (Pubitemid 41099645)
91. Wisplinghoff H, Seifert H, Wenzel RP, Edmond MB (2003) Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. Clin Infect Dis 36:1103-1110 (Pubitemid 36553108)
92. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB (2004) Nosocomial bloodstream infections in US hospitals: analysis of 24, 179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39:309-317
93. Wisplinghoff H, Seifert H, Tallent SM, Bischoff T, Wenzel RP, Edmond MB (2003) Nosocomial bloodstream infections in pediatric patients in United States hospitals: epidemiology, clinical features and susceptibilities. Pediatr Infect Dis J 22:686-691 (Pubitemid 36999643)
94. Mylotte JM, Kahler L, McCann C (2001) Community-acquired bacteremia at a teaching versus a nonteaching hospital: impact of acute severity of illness on 30-day mortality. Am J Infect Control 29:13-19
95. Moreillon P, Que Y-A, Glauser MP (2005) Staphylococcus aureus (including staphylococcal toxic shock). In: Mandell GL, Bennett JE, Dolin R (eds) Principles and practice of infectious diseases, 6th edn. Elsevier, Philadelphia, pp 2321-2351
96. Bayer AS, Ramos MD, Menzies BE, Yeaman MR, Shen AJ, Cheung AL (1997) Hyperproduction of alpha-toxin by Staphy-lococcus aureus results in paradoxically reduced virulence in experimental endocarditis: a host defense role for platelet microbicidal proteins. Infect Immun 65:4652-4660
97. Hawiger J, Streackley S, Hammond D, Chang C, Timmons S, Glick A, desPrez RM (1979) Staphylococcal-induced human platelet injury mediated by protein A and immunoglobulin G Fc receptor. J Clin Invest 64:931-937 (Pubitemid 10232569)
98. Sullam PM, Payan DG, Dazin PF, Valone FH (1990) Binding of viridans group streptococci to human platelets: a quantitative analysis. Infect Immun 58:3802-3806
99. Yeaman MR, Sullam PM, Dazin PF, Bayer AS (1992) Characterization of Staphylococcus aureus-platelet binding by quantitative flow cytometric analysis. J Infect Dis 166:65-73
100. Bayer AS, Sullam PM, Ramos M, Li C, Cheung AL, Yeaman MR (1995) Staphylococcus aureus induces platelet aggregation via a fibrinogen-dependent mechanism which is independent of principal platelet glycoprotein IIb/IIIa fibrinogen binding domains. Infect Immun 63:3634-3641
101. Siboo IR, Chambers HF, Sullam PM (2005) Role of SraP, a serine-rich surface protein of Staphylococcus aureus in binding to human platelets. Infect Immun 73:2273-2280
102. Niemann S, Spehr N, van Aken H, Morgenstern E, Peters G, Herrmann M, Kehrel BE (2004) Soluble fibrin is the main mediator of Staphylococcus aureus adhesion to platelets. Circulation 110:193-200
103. Cheung AL, Krishnan M, Jaffe EA, Fischetti VA (1991) Fibrinogen acts as a bridging molecule in the adherence of Staphylococcus aureus to cultured human endothelial cells. J Clin Invest 87:2236-2245
104. Clawson CC, White JG, Herzberg MC (1980) Platelet interaction with bacteria. VI. Contrasting the role of fibrinogen and fibronectin. Am J Hematol 9:43-53
105. Toy PTCY, Lai L-W, Drake TA, Sande MA (1985) Effect of fibronectin on adherence of Staphylococcus aureus to fibrin thrombi in vitro. Infect Immun 48:83-86
106. Herrmann M, Suchard SJ, Boxer LA, Waldvogel FA, Lew PD (1991) Thrombospondin binds to Staphylococcus aureus and promotes staphylococcal adherence to surfaces. Infect Immun 59:271-288
107. Loughman A, Fitzgerald JR, Brennan MP, Higgins J, Downer R, Cox D, Foster TJ (2005) Roles for fibrinogen, immunoglobulin and complement in platelet activation promoted by Staphylo-coccus aureus clumping factor A. Mol Microbiol 57:804-818
108. Nguyen T, Ghebrehiwet B, Peerschke EI (2000) Staphylococcus aureus protein A recognizes platelet gC1qR/p33: a novel mechanism for staphylococcal interactions with platelets. Infect Immun 68:2061-2068
109. Youssefian T, Drouin A, Masse JM, Guichard J, Cramer EM (2002) Host defense role of platelets: engulfment of HIV and Staphylococcus aureus occurs in a specific subcellular compartment and is enhanced by platelet activation. Blood 99:4021-4029
110. Brennan M, Loughman A, Devocelle M, Arasu S, Chubb AJ, Foster TJ, Cox D (2009) Elucidating the role of Staphylococcus epidermidis serine-aspartate repeat protein G (SdrG) in platelet activation. J Thromb Haemost 7:1364-1372
111. Gong K, Herzberg MC (1997) Streptococcus sanguis expresses a 150-kilodalton two-domain adhesin: characterization of several independent adhesin epitopes. Infect Immun 65:3815-3821
112. Zimmerman TS, Spregelberg HL (1975) Pneumococcus-induced serotonin release from human platelets. Identification of the participating plasma/serum factor as immunoglobulin. J Clin Invest 56:828-834
113. Ford I, Douglas CWI, Preston SE, Lawless A, Hampton KK (1993) Mechanisms of platelet aggregation by Streptococcus sanguis, a causative organism in infective endocarditis. Br J Hematol 84:85-100
114. Kurpiewski GE, Forrester LJ, Campbell BJ, Barrett JT (1983) Platelet aggregation by Streptococcus pyogenes. Infect Immun 39:704-708
115. Johnson CM, Bowie EJW (1992) Pigs with von Willebrand disease may be resistant to experimental infective endocarditis. J Lab Clin Med 120:553-558
116. Kerrigan SW, Jakubovics NS, Keane C, Maguire P, Wynne K, Jenkinson HF, Cox D (2007) Role of Streptococcus gordonii surface proteins SspA/SspB and Hsa in platelet function. Infect Immun 75:5740-5747
117. Sullam PM, Jarvis GA, Valone FH (1988) Role of immuno-globulin G in platelet aggregation by viridans group streptococci. Infect Immun 56:2907-2911
118. Bensing BA, Rubens CE, Sullam PM (2001) Genetic loci of Streptoccus mitis that mediate binding to human platelets. Infect Immun 69:1373-1380
119. Mitchell J, Siboo IR, Takamatsu D, Chambers HF, Sullam PM (2007) Mechanism of cell surface expression of the Streptococcus mitis platelet binding proteins PblA and PblB. Mol Microbiol 64:844-857
120. Mitchell J, Sullam PM (2009) Streptococcus mitis phage-enco-ded adhesins mediate attachment to a-2-8-linked sialic acid residues on platelet membrane gangliosides. Infect Immun 77:3485-3490
121. Xiong YQ, Bensing BA, Bayer AS, Chambers HF, Sullam PM (2008) Role of the serine-rich surface glycoprotein GspB of Streptococcus gordonii in the pathogenesis of infective endo carditis. Microb Pathog 45:297-301
122. Takamatsu D, Bensing BA, Sullam PM (2004) Four proteins encoded in the gspB-secY2A2 operon of Streptococcus gordonii mediate the intracellular glycosylation of the platelet-binding protein GspB. J Bacteriol 186:7100-7111
123. Ohba M, Shibazaki M, Sasano T, Inoue M, Takada H, Endo Y (2004) Platelet responses and anaphylaxis-like shock induced in mice by intravenous injection of whole cells of oral streptococci. Oral Microbiol Immunol 19:26-30
124. Rasmussen M, Eden A, Bjorck L (2000) SclA, a novel collagenlike surface protein of Streptococcus pyogenes. Infect Immun 69:6370-6377
125. Pietrocola G, Schubert A, Visai L, Torti M, Fitzgerald JR, Foster TJ, Reinscheid DJ, Speziale P (2005) FbsA, a fibrinogen-binding protein from Streptococcus agalactiae, mediates platelet aggregation. Blood 105:1052-1059
126. Coutinho IR, Berk RS, Mammen E (1988) Platelet aggregation by a phospholipase C from Pseudomonas aeruginosa. Thromb Res 51:495-505
127. Machado GB, de Assis MC, Leão R, Saliba AM, Silva MC, Suassuna JH, de Oliveira AV, Plotkowski MC (2009) ExoU-induced vascular hyperpermeability and platelet activation in the course of experimental Pseudomonas aeruginosa pneumosepsis. Shock [Epub ahead of print]
128. Shepel M, Boyd J, Luider J, Gibb AP (2001) Interaction of Yersinia enterocolitica and Y. pseudotuberculosis with platelets. J Med Microbiol 50:1030-1038
129. Bhat MA, Bhat JI, Kawoosa MS, Ahmad SM, Ali SW (2009) Organism-specific platelet response and factors affecting survival in thrombocytopenic very low birth weight babies with sepsis. J Perinatol 29:702-708
130. Fodor J (1887) Die fahigkeit des blutes bakterien zu vernichten. Dtsch Med Wochenschr 13:745-747
131. Gengou O (1901) De l'origine de l'axenine de serums normaux. Ann Inst Pasteur (Paris) 15:232-245
132. Hirsch JG (1960) Comparative bactericidal activities of blood serum and plasma serum. J Exp Med 112:15-22
133. Jago R, Jacox RF (1961) Cellular source and character of a heat-stable bactericidal property associated with rabbit and rat platelets. J Exp Med 113:701-709
134. Weksler BB (1971) Induction of bactericidal activity in human platelets. Clin Res 19:434-435
135. Kahn RA, Flinton LJ (1974) The relationship between platelets and bacteria. Blood 44:715-721
136. Miragliotta G, Lafata M, Jirilla E (1988) Antibacterial activity mediated by human platelets. Agents Actions 25:401-406
137. Carroll SF, Martinez RJ (1981) Antibacterial peptide from normal rabbit serum. I. Isolation from whole serum, activity, and microbiologic spectrum. Biochemistry 20:5973-5981
138. Carroll SF, Martinez RJ (1981) Antibacterial peptide from normal rabbit serum. II. Compositional microanalysis. Biochemistry 20:5981-5987
139. Carroll SF, Martinez RJ (1981) Antibacterial peptide from normal rabbit serum. III. Inhibition of microbial electron transport. Biochemistry 20:5988-5994
140. Myrvik QN (1956) Serum bactericidins active against Gram-positive bacteria. Ann NY Acad Sci 66:391-400
141. Myrvik QN, Leake ES (1960) Studies on antibacterial factors in mammalian tissues and fluids. IV. Demonstration of two non-dialyzable components in the serum bactericidin system for Bacillus subtilis. J Immunol 84:247-250
142. Johnson FB, Donaldson DM (1968) Purification of staphylocidal b-lysin from rabbit serum. J Bacteriol 96:589-595
143. Donaldson DM, Tew JG (1977) b-lysin of platelet origin. Bac-teriol Rev 41:501-512
144. Weksler BB, Nachman RL (1971) Rabbit platelet bactericidal protein. J Exp Med 134:1114-1130
145. Tew JG, Roberts RR, Donaldson DM (1974) Release of b-lysin from platelets by thrombin and by a factor produced in hepa-rinized blood. Infect Immun 9:179-186
146. Dankert J (1988) Role of platelets in early pathogenesis of viridans group streptococcal endocarditis. PhD dissertation, University of Groningen, The Netherlands
147. Dankert J, van der Werff J, Zaat SAJ, Joldersma W, Klein D, Hess J (1995) Involvement of bactericidal factors from throm-bin-stimulated platelets in clearance of adherent viridans streptococci in experimental infective endocarditis. Infect Immun 63:663-671
148. Darveau RP, Blake J, Seachord CL, Cosand WL, Cunningham MD, Cassiano-Cough L, Maloney G (1992) Peptide related to the carboxy-terminus of human platelet factor IV with antibacterial activity. J Clin Invest 90:447-455
149. Dürr M, Peschel A (2002) Chemokines meet defensins: the merging concepts of chemoattractants and antimicrobial pep-tides in host defense. Infect Immun 70:6515-6517
150. Cole AM, Ganz T, Liese AM, Burdick MD, Liu L, Strieter RM (2001) Cutting edge: IFN-inducible ELR-CXC chemokines display defensin-like antimicrobial activity. J Immunol 167:623-627
151. Yang D, Chen Q, Hoover DM, Staley P, Tucker KD, Lub-kowski J, Oppenheim JJ (2003) Many chemokines including CCL20/MIP-3a display antimicrobial activity. J Leukoc Biol 74:448-455
152. Tang YQ, Yeaman MR, Selsted ME (1995) Microbicidal and synergistic activities of human platelet factor-4 (hPF-4) and connective tissue activating peptide-3 (CTAP-3). Blood 86:556a
153. Tang YQ, Yeaman MR, Selsted ME (2002) Antimicrobial proteins from human platelets. Infect Immun 70:6524-6533
154. Yeaman MR, Puentes SM, Norman DC, Bayer AS (1992) Partial purification and staphylocidal activity of thrombin-induced platelet microbicidal protein. Infect Immun 60:1202-1209
155. Yeaman MR, Tang Y-Q, Shen AJ, Bayer AS, Selsted ME (1997) Purification and in vitro activities of rabbit platelet microbicidal proteins. Infect Immun 65:1023-1031
156. Yount NY, Gank KD, Xiong YQ, Bayer AS, Pender T, Welch WH, Yeaman MR (2004) Platelet microbicidal protein-1: structural themes of a multifunctional antimicrobial peptide. Antimicrob Agents Chemother 48:4395-4404
157. Yeaman MR, Yount NY (2005) Code among chaos: immuno-relativity and the AEGIS model of antimicrobial peptides. Microbe 71:21-27
158. Yeaman MR (2004) Antimicrobial peptides from platelets in defense against cardiovascular infections. In: Devine DA, Hancock REW (eds) Mammalian host defense peptides. Cambridge University Press, Cambridge, pp 279-322
159. Yeaman MR, Waring AJ, Yount NY, Gank KD, Wiese R, Bayer AS, Welch WH (2007) Modular determinants of antimicrobial activity in platelet factor-4 family kinocidins. Biochem Biophys Acta 1768:609-619
160. Yount NY, Andrés MT, Fierro JF, Yeaman MR (2007) The c-core motif correlates with antimicrobial activity in Cys-con-taining kaliocin-1 originating from transferrins. Biochem Biophys Acta 1768:2862-2872
161. Yeaman MR, Yount NY (2007) Unifying themes in host defense effector polypeptides. Nature Rev Microbiol 5:727-740
162. Yount NY, Waring AJ, Gank KD, Welch WH, Kupferwasser D, Yeaman MR (2007) Structural correlates of antimicrobial activity in IL-8 and related human kinocidins. Biochem Biophys Acta 1768:598-608
163. Yount NY, Yeaman MR (2004) Multidimensional signatures in antimicrobial peptides. Proc Natl Acad Sci USA 101:7363-7368
164. Anderson RC, Rehders M, Yu PL (2008) Antimicrobial fragments of the pro-region of cathelicidins and other immune peptides. Biotechnol Lett 30:813-818
165. Yeaman MR, Gank KD, Bayer AS, Brass EP (2002) Synthetic peptides that exert antimicrobial activities in whole blood and blood-derived matrices. Antimicrob Agents Chemother 46:3883-3891
166. Azizi N, Li C, Shen AJ, Bayer AS, Yeaman MR (1996) Staphylococcus aureus elicits release of platelet microbicidal proteins in vitro. Abstract no. 866, 36th Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans
167. Krijgsveld J, Zaat SA, Meeldijk J, van Veelen PA, Fang G, Poolman B, Brandt E, Ehlert JE, Kuijpers AJ, Engbers GH, Feijen J, Dankert J (2000) Thrombocidins, microbicidal proteins from human blood platelets, are C-terminal deletion products of CXC chemokines. J Biol Chem 275:20374-20381
168. Yeaman MR, Yount NY, Edwards JE Jr., Brass EP (2006) Multifunctional context-activated protides and methods of use. US patent number 7,067,621
169. Sieprawska-Lupa M, Mydel P, Krawczyk K, Wojcik K, Puklo M, Lupa B, Suder P, Silberring J, Reed M, Pohl J, Shafer W, McAleese F, Foster T, Travis J, Potempa J (2004) Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases. Antimicrob Agents Chemother 48:4673-4679
170. Yount NY, Kupferwasser D, Spisni A, Waring AJ, Sharma S, Zachary Z, Ramjan H, Yeaman MR (2009) Selective reciprocity in antimicrobial activity versus cytotoxicity of hBD-2 and cro-tamine. Proc Natl Acad Sci USA (in press)
171. Schaffner A, King CC, Schaer D, Guiney DG (2004) Induction and antimicrobial activity of platelet basic protein derivatives in human monocytes. J Leukoc Biol 76:1010-1018 (Pubitemid 39458712)
172. Zaiou M, Nizet V, Gallo RL (2003) Antimicrobial and protease inhibitory functions of the human cathelicidin (hCAP18/LL-37) prosequence. J Invest Dermatol 120:810-816
173. 12 receptor-induced amplification and kinocidin release. Infect Immun 76:5706-5713
174. Sharma A, Novak EK, Sojar HT, Swank RT, Kuramitsu HK, Genco RJ (2000) Porphyromonas gingivalis platelet aggregation activity: outer membrane vesicles are potent activators of mur-ine platelets. Oral Microbiol Immunol 15:393-396
175. Yeaman MR, Yount NY (2003) Mechanisms of antimicrobial peptide action and resistance. Pharm Rev 55:27-55
176. Mercier RC, Rybak MJ, Bayer AS, Yeaman MR (2000) Influence of platelets and platelet microbicidal protein susceptibility on the fate of Staphylococcus aureus in an in vitro model of infective endocarditis. Infect Immun 68:4699-4705
177. Mercier RC, Dietz RM, Mazzola JL, Bayer AS, Yeaman MR (2004) Beneficial influence of platelets on antibiotic efficacy in an in vitro model of Staphylococcus aureus endocarditis. Anti-microb Agents Chemother 48:2551-2557
178. Yeaman MR, Sullam PM, Dazin PF, Bayer AS (1994) Platelet microbicidal protein alone and in combination with antibiotics reduces Staphylococcus aureus adherence to platelets in vitro. Infect Immun 62:3416-3423
179. Yeaman MR, Sullam PM, Dazin PF, Ghannoum MA, Edwards JE Jr, Bayer AS (1994) Fluconazole and platelet microbicidal protein inhibit Candida adherence to platelets in vitro. Anti-microb Agents Chemother 38:1460-1465
180. Filler SG, Joshi M, Phan QT, Diamond RD, Edwards JE Jr, Yeaman MR (1999) Platelets protect vascular endothelial cells from injury due to Candida albicans. Abstract 2163, 39th ICAAC Meeting. American Society for Microbiology, San Francisco
181. Yeaman MR, Bayer AS (2000) Staphylococcus aureus, platelets, and the heart. Current Infect Dis Rep 2:281-298
182. Lorenz R, Brauer M (1988) Platelet factor-4 (PF4) in septicaemia. Infection 16:273-276
183. Mezzano S, Burgos ME, Ardiles L, Olavarria F, Concha M, Caorsi I, Aranda E, Mezzano D (1992) Glomerular localization of platelet factor 4 in streptococcal nephritis. Nephron 61:58-63
184. Wilson M, Blum R, Dandona P, Mousa S (2001) Effects in humans of intravenously administered endotoxin on soluble cell-adhesion molecule and inflammatory markers: a model of human diseases. Clin Exp Pharmacol Physiol 28:376-380
185. Sullam PM, Frank U, Yeaman MR, Tauber MG, Bayer AS, Chambers HF (1993) Effect of thrombocytopenia on the early course of streptococcal endocarditis. J Infect Dis 168:910-914
186. Dankert J, Krijgsveld J, van der Werff J, Joldersma W, Zaat SA (2001) Platelet microbicidal activity is an important defense factor against viridans streptococcal endocarditis. J Infect Dis 184:597-605
187. Viscoli C, Bruzzi P, Castagnola E, Boni L, Calandra T, Gaya H, Meuneir F, Feld R, Zinner S, Klastersky J et al (1994) Factors associated with bacteraemia in febrile, granulocytopenic patients. The International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC). Eur J Cancer 30:430-437
188. Feldman C, Kallenbach JM, Levy H, Thorburn JR, Hurwitz MD, Koornhof HJ (1991) Comparision of bacteraemic community-acquired lobar pneumonia due to Streptococcus pneumoniae and Klebsiella pneumoniae in an intensive care unit. Respiration 58:265-270
189. Chang FY, Singh N, Gayowski T, Wagener MM, Mietzner SM, Stout JE, Marino IR (2000) Thrombocytopenia in liver transplant recipients: predictors, impact on fungal infections, and role of endogenous thrombopoietin. Transplantation 69:70-75 (Pubitemid 30062611)
190. Smith-Erichsen N (1985) Serial determinations of platelets, leukocytes, and coagulation parameters in surgical septicemia. Scand J Clin Lab Invest 178:7-14
191. Santolaya ME, Alvarez AM, Aviles CL, Becker A, Cofre J, Enriquez N, O'Ryan M, Paya E, Salgado C, Silva P, Tordecilla J, Varas M, Villarroel M, Viviani T, Zubieta M (2002) Prospective evaluation of a model of prediction of invasive bacterial infection risk among children with cancer, fever, and neutro-penia. Clin Infect Dis 35:678-683
192. Yoshida T, Tsushima K, Tsuchiya A, Nishikawa N, Shirahata K, Kaneko K, Ito K, Kawakami H, Nakagawa S, Suzuki T, Kubo K, Ikeda S (2005) Risk factors for hospital-acquired bacteremia. Intern Med 44:1157-1162
193. Mavrommatis AC, Theodoridis T, Orfanidou A, Roussos C, Christopoulou-Kokkinou V, Zakynthinos S (2000) Coagulation system and platelets are fully activated in uncomplicated sepsis. Crit Care Med 28:451-457
194. Sun H, Wang X, Degen JL, Ginsburg D (2009) Reduced thrombin generation increases host susceptibility to group A streptococcal infection. Blood 113:1358-1364